The first Russian device for testing TB is registered
14 January 2025
A Russian company, Generium, has received registration for its medical device “ScreenSpot,” an analyzer designed for the automated reading and analysis of tuberculosis test results. This equipment is intended for use in clinical diagnostic laboratories, as reported by the company’s press service.
Russians spend 1.6 trillion rubles on medications in 2024
14 January 2025
In 2024, Russians spent approximately 1.6 trillion rubles on medications. According to the press service of the Center for the Development of Advanced Technologies, this represents a 1.4% increase in the number of packages sold.
2024 drug approvals: Small companies loom large with several key FDA nods
13 January 2025
Comparing the FDA new drug approval lists from 2023 and 2024 reveals a significant difference in the size of the companies that achieved the regulatory triumphs. In 2023, among the 68 FDA approvals highlighted in Fierce Pharma’s annual report, 43 (63%) were sponsored or co-sponsored by companies that generated at least $3 billion in revenue in 2023. That stands in contrast to the 2024 approval list, which shows that among 55 FDA nods, just 23 (42%) were sponsored or co-sponsored by companies with sales that reached $3 billion in 2023.
Special Regulations for Foreign-Packaged Medicines Extended Until the End of 2025
13 January 2025
The Russian government has decided to extend the special regulations for the circulation of medicines in foreign packaging, complete with Russian-language labels, through 2025. This decision was made to prevent shortages and ensure a stable supply of medications in pharmacies and medical institutions.
Russia Begins Production of Terbium-161 Isotope for Cancer Therapy
10 January 2025
Russia has commenced the production of the innovative medical isotope terbium-161, intended for cancer therapy. This production process has been established by specialists at the Institute of Reactor Materials, part of Rosatom’s scientific division, located in the Sverdlovsk region. The first experimental batch of the isotope will be used for testing at the Russian Research Center for Radiology and Surgical Technologies (RNCRH), which specializes in nuclear medicine research and the development of radiopharmaceuticals.
FMBA has begun clinical trials of a vaccine against five serotypes of meningococcus
10 January 2025
The Federal Medical and Biological Agency of Russia has initiated the first phase of clinical trials for an innovative vaccine against meningococcus, named MCV-5. According to the agency’s press service, the vaccine’s safety, immunogenicity, and protective properties were established during preclinical trials.
FDA issues first recommendations on AI for drug development
09 January 2025
The new US Food and Drug Administration (FDA) guidance will enhance credibility of AI models in drug and biological product regulatory submissions.
Personal Data in European Medicine Regulation
28 December 2024
EMA and HMA have published revised guidelines on identification of commercially confidential information and personal data used in marketing authorization applications.
Belarus Republic creates production of oncology drugs for 1.5 billion rubles
27 December 2024
A new pharmaceutical production facility has been launched in the Minsk Free Economic Zone. The enterprise of the Onco Solutions company will focus on the production of sterile parenteral forms of antitumor drugs.
Tyumen Medical University has developed a lancet for diagnosing five socially significant diseases
27 December 2024
Tyumen State Medical University specialists have created a patented lancet-type diagnostic device that enables quick testing for five important diseases: HIV, syphilis, tuberculosis, and hepatitis B and C.
Merry Christmas and Happy New Year!
28 December 2024
NovaMedica team in the TOP 100 INFLUENTIAL PEOPLE IN THE PHARMACEUTICAL BUSINESS 2024
28 November 2024
05 November 2024
The first Russian device for testing TB is registered
14 January 2025
Russians spend 1.6 trillion rubles on medications in 2024
14 January 2025
2024 drug approvals: Small companies loom large with several key FDA nods
13 January 2025
Special Regulations for Foreign-Packaged Medicines Extended Until the End of 2025
13 January 2025